Experienced in Hepatitis A

Dr. Gyongyi Szabo

Gastroenterology
330 Brookline Ave, 
Boston, MA 
Accepting New Patients
36 Years of Experience
Experienced in Hepatitis A
330 Brookline Ave, 
Boston, MA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Gyongyi Szabo is a Gastroenterologist in Boston, Massachusetts. Dr. Szabo has been practicing medicine for over 36 years and is rated as an Experienced provider by MediFind in the treatment of Hepatitis A. Her top areas of expertise are Hepatitis, Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), Liver Transplant, and Colonoscopy. Dr. Szabo is currently accepting new patients.

Her clinical research consists of co-authoring 258 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Hepatitis A.

Specialties
Gastroenterology
Licenses
Internal Medicine in MA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO

Locations

330 Brookline Ave, Boston, MA 02215

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network - A Longitudinal, Observational Study.
HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network - A Longitudinal, Observational Study.
Enrollment Status: Completed
Publish Date: February 28, 2024
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Patients With Primary Biliary Cholangitis
A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Patients With Primary Biliary Cholangitis
Enrollment Status: Terminated
Publish Date: March 09, 2023
Intervention Type: Drug
Study Drug: Obeticholic Acid 
Study Phase: Phase 4
A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults With Nonalcoholic Steatohepatitis (NASH)
A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults With Nonalcoholic Steatohepatitis (NASH)
Enrollment Status: Terminated
Publish Date: November 25, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

257 Total Publications

Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease.
Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease.
Journal: Nature reviews. Gastroenterology & hepatology
Published: August 28, 2025
Similar Doctors
Advanced in Hepatitis A
Dr. Laurence Bailen
Gastroenterology
Advanced in Hepatitis A
Dr. Laurence Bailen
Gastroenterology

Gastroenterology Healthcare Associates PC

2000 Washington St, Suite 368, 
Newton, MA 
 (7.2 miles away)
617-969-1227
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Laurence Bailen is a Gastroenterologist in Newton, Massachusetts. Dr. Bailen is rated as a Distinguished provider by MediFind in the treatment of Hepatitis A. His top areas of expertise are Turcot Syndrome, Gardner Syndrome, Familial Adenomatous Polyposis, Endoscopy, and Colonoscopy.

Experienced in Hepatitis A
Dr. Raffi Karagozian
Gastroenterology | Transplant Surgery | Pulmonary Medicine
Experienced in Hepatitis A
Dr. Raffi Karagozian
Gastroenterology | Transplant Surgery | Pulmonary Medicine

Pratt Medical Group Inc

800 Washigton St, 
Boston, MA 
 (2.2 miles away)
617-636-5000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Raffi Karagozian is a Gastroenterologist and a Transplant Surgeon in Boston, Massachusetts. Dr. Karagozian is rated as a Distinguished provider by MediFind in the treatment of Hepatitis A. His top areas of expertise are Cirrhosis, Hepatitis, Malnutrition, Small Bowel Resection, and Endoscopy. Dr. Karagozian is currently accepting new patients.

Experienced in Hepatitis A
Dr. Arslan Talat
Gastroenterology
Experienced in Hepatitis A
Dr. Arslan Talat
Gastroenterology

Cambridge Public Health Commission

1493 Cambridge St, 
Cambridge, MA 
 (2.4 miles away)
617-665-1000
Languages Spoken:
English
See accepted insurances

Arslan Talat is a Gastroenterologist in Cambridge, Massachusetts. Dr. Talat is rated as an Experienced provider by MediFind in the treatment of Hepatitis A. His top areas of expertise are Pancreas Divisum, Liver Failure, Childhood Pancreatitis, Endoscopy, and Liver Transplant.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Szabo's expertise for a condition
ConditionClose
    View All 14 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile